Related references
Note: Only part of the references are listed.mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging
Candice E. Van Skike et al.
AGING CELL (2020)
Rapamycin persistently improves cardiac function in aged, male and female mice, even following cessation of treatment
Ellen Quarles et al.
AGING CELL (2020)
Metformin mediates cardioprotection against aging-induced ischemic necroptosis
Chen Li et al.
AGING CELL (2020)
Metformin use is associated with a lower risk of osteoporosis in adult women independent of type 2 diabetes mellitus and obesity. REDLINC IX study
Juan E. Blumel et al.
GYNECOLOGICAL ENDOCRINOLOGY (2020)
Targeted Reduction of Senescent Cell Burden Alleviates Focal Radiotherapy-Related Bone Loss
Abhishek Chandra et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Metformin Treatment for Diabetes Mellitus Correlates with Progression and Survival in Colorectal Carcinoma
Marta K. Powell et al.
TRANSLATIONAL ONCOLOGY (2020)
Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity
Estela Gonzalez-Gualda et al.
AGING CELL (2020)
Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice
Yusheng Cai et al.
CELL RESEARCH (2020)
Fisetin attenuates isoproterenol-induced cardiac ischemic injury in vivo by suppressing RAGE/NF-κB mediated oxidative stress, apoptosis and inflammation
Shanky Garg et al.
PHYTOMEDICINE (2019)
Length-independent telomere damage drives post-mitotic cardiomyocyte senescence
Rhys Anderson et al.
EMBO JOURNAL (2019)
Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy
Osama Y. Althunibat et al.
LIFE SCIENCES (2019)
Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease
Alexander B. Pupyshev et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model
Peisu Zhang et al.
NATURE NEUROSCIENCE (2019)
Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis
Yechen Han et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Effect of caloric restriction and rapamycin on ovarian aging in mice
Driele N. Garcia et al.
GEROSCIENCE (2019)
The advantages of UK Biobank's open-access strategy for health research
M. Conroy et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
LaTonya J. Hickson et al.
EBIOMEDICINE (2019)
Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis
Peter Hanlon et al.
BMC MEDICINE (2019)
Cellular Senescence: Defining a Path Forward
Vassilis Gorgoulis et al.
CELL (2019)
Fisetin Alleviates Atrial Inflammation, Remodeling, and Vulnerability to Atrial Fibrillation after Myocardial Infarction
Liang Liu et al.
INTERNATIONAL HEART JOURNAL (2019)
Rapamycin improves healthspan but not inflammaging in nfb1-/- mice
Clara Correia-Melo et al.
AGING CELL (2019)
Topical rapamycin reduces markers of senescence and aging in human skin: an exploratory, prospective, randomized trial
Christina Lee Chung et al.
GEROSCIENCE (2019)
Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
Mikolaj Ogrodnik et al.
CELL METABOLISM (2019)
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Jamie N. Justice et al.
EBIOMEDICINE (2019)
Aged-senescent cells contribute to impaired heart regeneration
Fiona C. Lewis-McDougall et al.
AGING CELL (2019)
Pharmacological clearance of senescent cells improves survival and recovery in aged mice following acute myocardial infarction
Anna Walaszczyk et al.
AGING CELL (2019)
Metformin Alters Locomotor and Cognitive Function and Brain Metabolism in Normoglycemic Mice
Wenjun Li et al.
AGING AND DISEASE (2019)
mTOR drives cerebral blood flow and memory deficits in LDLR-/- mice modeling atherosclerosis and vascular cognitive impairment
Jordan B. Jahrling et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults
Ameya S. Kulkarni et al.
AGING CELL (2018)
Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment
Candice E. Van Skike et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Patient-centeredness of integrated care programs for people with multimorbidity. Results from the European ICARE4EU project
Iris van der Heide et al.
HEALTH POLICY (2018)
Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo
Long-Bin Jeng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Multimorbidity Trends in United States Adults, 1988-2014
Dana E. King et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2018)
Find drugs that delay many diseases of old age
Ilaria Bellantuono
NATURE (2018)
Senolytics improve physical function and increase lifespan in old age
Ming Xu et al.
NATURE MEDICINE (2018)
Fisetin Confers Cardioprotection against Myocardial Ischemia Reperfusion Injury by Suppressing Mitochondrial Oxidative Stress and Mitochondrial Dysfunction and Inhibiting Glycogen Synthase Kinase 3 beta Activity
Karthi Shanmugam et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Investigation of quercetin and hyperoside as senolytics in adult human endothelial cells
HyunTae V. Hwang et al.
PLOS ONE (2018)
TORC1 inhibition enhances immune function and reduces infections in the elderly
Joan B. Mannick et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson's Disease
Shankar J. Chinta et al.
CELL REPORTS (2018)
Tau protein aggregation is associated with cellular senescence in the brain
Nicolas Musi et al.
AGING CELL (2018)
Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
Jared M. Campbell et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Tyler J. Bussian et al.
NATURE (2018)
Opening the door to treating ageing as a disease
[Anonymous]
LANCET DIABETES & ENDOCRINOLOGY (2018)
Fisetin is a senotherapeutic that extends health and lifespan
Matthew J. Yousefzadeh et al.
EBIOMEDICINE (2018)
Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease
Ai-Ling Lin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Fisetin inhibits IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through activating SIRT1 and attenuates the progression of osteoarthritis in mice
Wenhao Zheng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Inhibition of Bcl-2/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice
Jin Pan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Differential effects of metformin on age related comorbidities in older men with type 2 diabetes
Chen-Pin Wang et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
The Clinical Potential of Senolytic Drugs
James L. Kirkland et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)
Targeting cellular senescence prevents age-related bone loss in mice
Joshua N. Farr et al.
NATURE MEDICINE (2017)
Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment
Ok Hee Jeon et al.
NATURE MEDICINE (2017)
Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease
Nikita Katila et al.
NEUROPHARMACOLOGY (2017)
Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease
Yunlong Zhang et al.
CELL DEATH & DISEASE (2017)
Cellular senescence mediates fibrotic pulmonary disease
Marissa J. Schafer et al.
NATURE COMMUNICATIONS (2017)
Cellular senescence drives age-dependent hepatic steatosis
Mikolaj Ogrodnik et al.
NATURE COMMUNICATIONS (2017)
A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs
Silvan R. Urfer et al.
GEROSCIENCE (2017)
Age-dependent Changes in the Articular Cartilage and Subchondral Bone of C57BL/6 Mice after Surgical Destabilization of Medial Meniscus
Henry Huang et al.
SCIENTIFIC REPORTS (2017)
Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis
Jared M. Campbell et al.
AGEING RESEARCH REVIEWS (2017)
Metformin and ageing: improving ageing outcomes beyond glycaemic control
Willy Marcos Valencia et al.
DIABETOLOGIA (2017)
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
Vanita R. Aroda et al.
DIABETOLOGIA (2017)
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
Simon J. Griffin et al.
DIABETOLOGIA (2017)
Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism
Rong Wang et al.
AGING CELL (2017)
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging
Marjolein P. Baar et al.
CELL (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice
Carolyn M. Roos et al.
AGING CELL (2016)
Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors
Yi Zhu et al.
AGING CELL (2016)
Safety of mTOR inhibitors in adult solid organ transplantation
Pedro Ventura-Aguiar et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson's Disease via Autophagy and Mitochondrial ROS Clearance
Ming Lu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial
Jose A. Luchsinger et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Interventions for age-related diseases: Shifting the paradigm
Ines Figueira et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2016)
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Darren J. Baker et al.
NATURE (2016)
Senescent intimal foam cells are deleterious at all stages of atherosclerosis
Bennett G. Childs et al.
SCIENCE (2016)
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Yi Zhu et al.
AGING CELL (2015)
Dietary flavonoid fisetin regulates aluminium chloride-induced neuronal apoptosis in cortex and hippocampus of mice brain
Dharmalingam Prakash et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)
Aging and Multimorbidity: New Tasks, Priorities, and Frontiers for Integrated Gerontological and Clinical Research
Elisa Fabbri et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2015)
Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model
Noriko Takahashi et al.
JOURNAL OF VASCULAR SURGERY (2015)
Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia
Ghorbangol Ashabi et al.
METABOLIC BRAIN DISEASE (2015)
The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy
Robert Siman et al.
PLOS ONE (2015)
Chronic rapamycin treatment causes diabetes in male mice
Christine E. Schindler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2014)
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Marco Demaria et al.
DEVELOPMENTAL CELL (2014)
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls
C. A. Bannister et al.
DIABETES OBESITY & METABOLISM (2014)
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Anila K. Madiraju et al.
NATURE (2014)
Incidence and Predictors of Multimorbidity in the Elderly: A Population-Based Longitudinal Study
Rene Melis et al.
PLOS ONE (2014)
mTOR inhibition improves immune function in the elderly
Joan B. Mannick et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Effect of Inhibiting the Signal of Mammalian Target of Rapamycin on Memory T Cells
S. Chen et al.
TRANSPLANTATION PROCEEDINGS (2014)
Local intra-articular injection of rapamycin delays articular cartilage degeneration in a murine model of osteoarthritis
Koji Takayama et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis
Farshad Forouzandeh et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Late-life rapamycin treatment reverses age-related heart dysfunction
James M. Flynn et al.
AGING CELL (2013)
Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-B activation
Olga Moiseeva et al.
AGING CELL (2013)
Prevalence and Risk of Potential Cytochrome P450-Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy
Julie Doan et al.
ANNALS OF PHARMACOTHERAPY (2013)
An oncolytic adenovirus enhances antiangiogenic and antitumoral effects of a replication-deficient adenovirus encoding endostatin by rescuing its selective replication in nasopharyngeal carcinoma cells
Ran-yi Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Duration of Rapamycin Treatment Has Differential Effects on Metabolism in Mice
Yimin Fang et al.
CELL METABOLISM (2013)
Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease
Ai-Ling Lin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Rapamycin extends murine lifespan but has limited effects on aging
Frauke Neff et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
mTOR is a key modulator of ageing and age-related disease
Simon C. Johnson et al.
NATURE (2013)
Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
Sefika Ozcelik et al.
PLOS ONE (2013)
Metformin improves healthspan and lifespan in mice
Alejandro Martin-Montalvo et al.
NATURE COMMUNICATIONS (2013)
Fisetin averts oxidative stress in pancreatic tissues of streptozotocin-induced diabetic rats
Gopalan Sriram Prasath et al.
ENDOCRINE (2013)
Prevention of Age-Related Macular Degeneration-Like Retinopathy by Rapamycin in Rats
Nataliya G. Kolosova et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Autophagy activation by rapamycin reduces severity of experimental osteoarthritis
Beatriz Carames et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
PHAGOCYTES & GRANULOCYTES The shady side of dasatinib
Alexander Zarbock
BLOOD (2012)
Dasatinib inhibits proinflammatory functions of mature human neutrophils
Krisztina Futosi et al.
BLOOD (2012)
Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage
Carolyn Algire et al.
CANCER PREVENTION RESEARCH (2012)
Characteristics of, and risk factors for, infections in patients with cancer treated with dasatinib and a brief review of other complications
Gilhen H. Rodriguez et al.
LEUKEMIA & LYMPHOMA (2012)
CHRONIC INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN BY RAPAMYCIN MODULATES COGNITIVE AND NON-COGNITIVE COMPONENTS OF BEHAVIOR THROUGHOUT LIFESPAN IN MICE
J. Halloran et al.
NEUROSCIENCE (2012)
Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure
Meimei Yin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Modulatory effects of fisetin, a bioflavonoid, on hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in hepatic and renal tissues in streptozotocin-induced diabetic rats
Gopalan Sriram Prasath et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits
Smita Majumder et al.
PLOS ONE (2011)
Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
Vladimir N. Anisimov et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
Quantitative assessment of markers for cell senescence
Conor Lawless et al.
EXPERIMENTAL GERONTOLOGY (2010)
Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau EFFECTS ON COGNITIVE IMPAIRMENTS
Antonella Caccamo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Rapamycin Protects against Neuron Death in In Vitro and In Vivo Models of Parkinson's Disease
Cristina Malagelada et al.
JOURNAL OF NEUROSCIENCE (2010)
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
Wyndham H. Wilson et al.
LANCET ONCOLOGY (2010)
Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-beta Levels in a Mouse Model of Alzheimer's Disease
Patricia Spilman et al.
PLOS ONE (2010)
DNA damage response and cellular senescence in tissues of aging mice
Chunfang Wang et al.
AGING CELL (2009)
Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus
Adriaan Kooy et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels
Wen Qiang Chen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Metformin - the gold standard in type 2 diabetes: what does the evidence tell us?
E. Bosi
DIABETES OBESITY & METABOLISM (2009)
mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells
Chong Chen et al.
SCIENCE SIGNALING (2009)
Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate
Michael Brave et al.
CLINICAL CANCER RESEARCH (2008)
Use of sirolimus in solid organ transplantation
Joshua J. Augustine et al.
DRUGS (2007)
Accumulation of senescent cells in mitotic tissue of aging primates
Jessie C. Jeyapalan et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2007)
Cellular senescence in aging primates
U Herbig et al.
SCIENCE (2006)
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
VN Anisimov et al.
EXPERIMENTAL GERONTOLOGY (2005)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
